320 related articles for article (PubMed ID: 22086188)
1. Nematode modulation of inflammatory bowel disease.
Whelan RA; Hartmann S; Rausch S
Protoplasma; 2012 Oct; 249(4):871-86. PubMed ID: 22086188
[TBL] [Abstract][Full Text] [Related]
2. Where are we on worms?
Elliott DE; Weinstock JV
Curr Opin Gastroenterol; 2012 Nov; 28(6):551-6. PubMed ID: 23079675
[TBL] [Abstract][Full Text] [Related]
3. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
4. Enteric nematodes and the path to up-regulation of type 2 cytokines IL-4 and IL-13.
Shea-Donohue T; Sun R; Bohl JA; McLean LP; Zhao A
Cytokine; 2015 Sep; 75(1):62-7. PubMed ID: 26188364
[TBL] [Abstract][Full Text] [Related]
5. The emering role of helminths in treatment of the inflammatory bowel disorders.
Szkudlapski D; Labuzek K; Pokora Z; Smyla N; Gonciarz M; Mularczyk A; Maluch P; Okopien B
J Physiol Pharmacol; 2014 Dec; 65(6):741-51. PubMed ID: 25554978
[TBL] [Abstract][Full Text] [Related]
6. Translatability of helminth therapy in inflammatory bowel diseases.
Weinstock JV; Elliott DE
Int J Parasitol; 2013 Mar; 43(3-4):245-51. PubMed ID: 23178819
[TBL] [Abstract][Full Text] [Related]
7. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease.
Heylen M; Ruyssers NE; Gielis EM; Vanhomwegen E; Pelckmans PA; Moreels TG; De Man JG; De Winter BY
Pharmacol Ther; 2014 Aug; 143(2):153-67. PubMed ID: 24603369
[TBL] [Abstract][Full Text] [Related]
8. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
9. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
Dharmani P; Chadee K
Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
[TBL] [Abstract][Full Text] [Related]
10. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
11. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
12. New therapies for inflammatory bowel disease: from the bench to the bedside.
Danese S
Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Pediatric Inflammatory Bowel Disease.
Peloquin JM; Goel G; Villablanca EJ; Xavier RJ
Annu Rev Immunol; 2016 May; 34():31-64. PubMed ID: 27168239
[TBL] [Abstract][Full Text] [Related]
14. Targeting the innate immune system in pediatric inflammatory bowel disease.
Schirbel A; Fiocchi C
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):33-41. PubMed ID: 21309670
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of inflammatory bowel disease for investigating mucosal immunity in the intestine.
Bamias G; Arseneau KO; Cominelli F
Curr Opin Gastroenterol; 2017 Nov; 33(6):411-416. PubMed ID: 28901966
[TBL] [Abstract][Full Text] [Related]
16. Intestinal helminths: a clue explaining the low incidence of inflammatory bowel diseases in Subsaharan Africa? Potential benefits and hazards of helminth therapy.
Fiasse R; Latinne D
Acta Gastroenterol Belg; 2006; 69(4):418-22. PubMed ID: 17343086
[TBL] [Abstract][Full Text] [Related]
17. Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.
Rutella S; Locatelli F
World J Gastroenterol; 2011 Sep; 17(33):3761-75. PubMed ID: 21987618
[TBL] [Abstract][Full Text] [Related]
18. Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses.
Blum AM; Hang L; Setiawan T; Urban JP; Stoyanoff KM; Leung J; Weinstock JV
J Immunol; 2012 Sep; 189(5):2512-20. PubMed ID: 22844110
[TBL] [Abstract][Full Text] [Related]
19. Lessons from genetic models of inflammatory bowel disease.
Podolsky DK
Acta Gastroenterol Belg; 1997; 60(2):163-5. PubMed ID: 9260328
[TBL] [Abstract][Full Text] [Related]
20. Current Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel Disease.
Seyedizade SS; Afshari K; Bayat S; Rahmani F; Momtaz S; Rezaei N; Abdolghaffari AH
Arch Immunol Ther Exp (Warsz); 2020 Apr; 68(2):10. PubMed ID: 32239308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
